Company
United StatesUPMC Hillman Cancer Center Riviera Facility, Pittsburgh, PA – FDA Inspections
Inspection records and compliance data for UPMC Hillman Cancer Center Riviera Facility in Pittsburgh, Pennsylvania. 1 FDA inspection on record, last inspected October 18, 2022.
Company Profile
This profile covers UPMC Hillman Cancer Center Riviera Facility based in Pittsburgh, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected October 18, 2022.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 18, 2022 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1182007 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
ITxM Clinical Service - Allegheny Valley Hospital
Hospital Of The University of Pennsylvania
Lancaster General Women and Babies Hospital Blood Bank
Elite Spine LLC
Blood Bank of Delmarva, a Division of New York Blood Center, Inc.
Janet S. Chen, M.D.
Medtronic Spinal and Biologics
Gregory L. Beatty M.D., PhD
HCSC Blood Center
Biomat USA Inc
Company Information
Name
UPMC Hillman Cancer Center Riviera Facility
FEI Number
3017870223
Address
350 Technology Dr Ste 611, Pittsburgh, Pennsylvania 15219, United States
Country
United States
ID: 84ddbe15-26ba-4ae9-9e0d-c3e581e61ced